We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLOB:NYSEGlobant S.A. Analysis

Data as of 2026-09-19 - not real-time

$35.59

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Globant S.A. is priced at $35.59, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has lost 4.5%. Relative strength is 41.8 — neutral — and the MACD signal is bearish. Recent trading has carved out support near $35.50 and resistance around $41.49.
On valuation the read is undervalued — earnings multiple of 13.9 versus a 33.6 sector average, below the peer group. Sell-side targets cluster 45.0% above the current quote.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 58.1%, a beta of 0.89 and a maximum drawdown of 61.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.

Top Market Events

/PRNewswire/ -- Globant S.A. NYSE: GLOB shareholders lost money when the Company's full-year 2026 revenue outlook went...Globant SA GLOB reports strong AI adoption and record first-half free cash flow, yet revises 2026 outlook amid Middle...WS Amati Global Innovation Fund, managed by a UK-based equity management firm from AMAti Global Investors, released its...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 46.51
  • MACD momentum is negative
  • 30-day volatility of 58.1%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 13.9 versus sector average of 33.6
  • Trading below the 200-day average of 46.51
  • Analyst targets imply +45.0% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 13.9 versus sector average of 33.6
  • Analyst targets imply +45.0% versus the current price
  • 30-day volatility of 58.1%

Key Metrics & Analysis

Financial Health

Profit Margin4.63%
P/E Ratio13.9
ROE5.48%
ROA4.67%
Debt/Equity23.82
P/B Ratio0.7
Industry P/E33.6

Technical Analysis

TrendNeutral
RSI41.8
Support$35.50
Resistance$41.49
MA 20$38.88
MA 50$36.77
MA 200$46.51
MACDBearish
VolumeIncreasing
Fear & Greed Index94.98

Valuation

Target Price$51.59
Upside/Downside44.96%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.89
Volatility58.13%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.